je.st
news
J&J profit rises 13% to $4.3-billion, beats forecast
2014-07-16 02:07:36| Biotech - Topix.net
Johnson & Johnson reported higher-than-expected quarterly revenue and earnings, benefiting from strong sales of its Olysio treatment for hepatitis C. The diversified healthcare company on Tuesday said it had earned $4.33-billion, or $1.51 per share, in the second quarter.
Tags: profit
forecast
beats
rises
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||